David C. Hastings
2019 - Arbutus Biopharma Corp
In 2019, David C. Hastings earned a total compensation of $1M as Chief Financial Officer at Arbutus Biopharma Corp, a 30% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $131,840 |
|---|---|
| Option Awards | $459,109 |
| Salary | $412,000 |
| Other | $7,301 |
| Total | $1,010,250 |
Hastings received $459.1K in option awards, accounting for 45% of the total pay in 2019.
Hastings also received $131.8K in non-equity incentive plan, $412K in salary and $7.3K in other compensation.
Rankings
In 2019, David C. Hastings' compensation ranked 9,215th out of 13,971 executives tracked by ExecPay. In other words, Hastings earned more than 34.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,215 out of 13,971 | 34th |
Division Manufacturing | 3,689 out of 5,695 | 35th |
Major group Chemicals And Allied Products | 1,400 out of 2,194 | 36th |
Industry group Drugs | 1,193 out of 1,880 | 37th |
Industry Pharmaceutical Preparations | 886 out of 1,392 | 36th |
Source: SEC filing on April 24, 2020.
Hastings' colleagues
We found three more compensation records of executives who worked with David C. Hastings at Arbutus Biopharma Corp in 2019.